D-Wave quantum CFO John Markovich sells $90,148 in stock

D-Wave Quantum CFO John M. Markovich sold 2,908 shares on June 2, 2026 at $31.00 per share, for total proceeds of $90,148, and now directly holds 1,439,912 shares including 447,770 unvested RSUs. The article also highlights D-Wave's 100 logical qubit roadmap by 2032 and a proposed $100 million CHIPS Act funding LOI, while Rosenblatt and Stifel reiterated Buy ratings with $43 and $35 price targets. Overall tone is mixed-to-neutral: the insider sale is modestly negative, but it is offset by strategic development and supportive analyst coverage.

Analysis

The market is still treating QBTS as a story stock, but the insider sale matters less as a directional signal than as a financing and credibility check. When management monetizes into strength while simultaneously leaning on long-dated platform promises, the stock becomes more sensitive to any delay in conversion from narrative to revenue, especially because valuation already discounts a lot of future success.

The bigger second-order effect is competitive: D-Wave’s push toward a broader full-stack roadmap is an implicit admission that the market is rewarding platform breadth over niche technical differentiation. That creates a window for better-capitalized quantum peers and adjacent enterprise compute vendors to poach the “strategic” label, while suppliers and government-funding counterparty risk become more important than headline breakthroughs. If the CHIPS-related funding stalls or is slower than expected, the gap between roadmap optics and cash needs could widen quickly over the next 2-3 quarters.

Near term, the stock is vulnerable to multiple compression rather than a fundamental collapse. A premium sale by an executive into a rally can cap follow-through buying for days to weeks, and any analyst-driven upside is likely to be traded rather than sustained unless there is a concrete commercialization milestone. The contrarian view is that the market may be overestimating how much of the forward value is already embedded; if execution slips even modestly, the downside re-rating could be steep because the shares still trade like an option on future relevance rather than current cash flow.

The cleanest setup is to fade strength rather than short into capitulation. The risk/reward improves if the name approaches prior support after a catalyst disappointment, because liquidity is thin and vol is high enough to make defined-risk structures attractive. For investors who want exposure to quantum without binary single-name risk, the better expression is a relative value basket against more established compute or software infrastructure beneficiaries.

Key Decisions for Investors

• Short QBTS on strength for a 2-6 week trade; use tight risk controls because upside squeezes are possible, but the stock is vulnerable to multiple compression if no hard commercial catalyst follows.
• Buy QBTS put spreads 1-3 months out rather than outright puts; this captures downside from execution disappointment while limiting theta bleed in a high-vol name.
• Pair trade: short QBTS vs long a profitable AI/compute infrastructure name over the next 1-2 quarters; the spread benefits if capital rotates away from pre-revenue quantum narratives toward cash-generating platforms.
• Do not chase analyst-target upside here; wait for either a funding confirmation or a material pullback before considering long exposure, since the current setup is more catalyst-dependent than trend-confirming.
• If holding QBTS, trim into any post-news rally and reassess only after there is evidence of revenue conversion or financing clarity over the next 90 days.